Search

everythinglearnresearchcommunity

for

Search:↓

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

New treatments for hair growth disorders are needed due to limited current options and complex hair follicle biology.

Dihydrotestosterone changes some hormone-related gene expressions in rat pituitary glands but doesn't affect the estrous cycle.

Hair greying is seen as a sign of aging; temporary fixes like hair dye are used, but a balanced diet and hair care can help manage it.

Most over-the-counter hair loss treatments lack strong evidence of effectiveness, except for minoxidil, which works but stops working if you stop using it.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

New treatments for male hypogonadism are effective and should be personalized.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Hair follicles can help wounds heal faster and this knowledge could be used to treat chronic skin ulcers, with a potential use of a special stem cell hydrogel to enhance healing.

The document concludes that understanding hair follicle cell cycles is crucial for hair growth and alopecia research, and recommends specific techniques and future research directions.

CIP/KIP proteins help stop cell division and support hair growth.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

A man experienced hair loss from radiotherapy, which can be temporary or permanent depending on radiation dose, with potential treatments available.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Children and adults with Cushing's disease show different symptoms and males have more severe cases; surgery outcomes can be predicted by certain factors.

Eplerenone, a mineralocorticoid receptor antagonist, was found to promote hair growth in human hair follicles.

Cats lose fur due to various reasons, including allergies, infections, genetics, hormones, diet, cancer, stress, and some conditions are treatable while others are not.

The study suggests that hypothyroidism may cause alopecia areata.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Stress and hormones like progesterone can affect absence seizures, but their effects change with different life stages.

Certain miRNAs play a key role in the growth of cashmere by affecting hair follicle development and regeneration.

Spermidine may help reduce hair loss and deserves further testing as a treatment.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Melatonin affects skin and hair color and protects skin cells, with potential benefits for hair growth and skin health.